NASDAQ:URGN | Insider Transactions — Page 2 | UroGen Pharma Ltd.

URGN Insider Transactions — Page 2

113 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 101–113; provenance stays internal.

Insider profileRoleDateTransactionSharesPrice
Mullennix StephenChief Operating Officer2019-08-15Sale608.0$31.65
Mullennix StephenChief Operating Officer2019-05-14Sale608.0$37.98
Schoenberg MarkChief Medical Officer2019-03-21Purchase272.0$37.01
Schoenberg MarkChief Medical Officer2019-03-06Sale1,991.0$37.3
Mullennix StephenChief Operating Officer2019-02-14Sale2,804.0$37.3
Moorin JayTenPercentOwner2017-11-28Sale177,807.0$40.51
SCHREIBER ALAINTenPercentOwner2017-11-28Sale177,807.0$40.51
ProQuest Investments IV, L.P.TenPercentOwner2017-11-28Sale177,807.0$40.51
ProQuest Associates IV LLCTenPercentOwner2017-11-28Sale177,807.0$40.51
Moorin JayTenPercentOwner2017-11-27Sale31,491.0$41.12
SCHREIBER ALAINTenPercentOwner2017-11-27Sale31,491.0$41.12
ProQuest Investments IV, L.P.TenPercentOwner2017-11-27Sale31,491.0$41.12
ProQuest Associates IV LLCTenPercentOwner2017-11-27Sale31,491.0$41.12